0001479290-22-000071.txt : 20220513 0001479290-22-000071.hdr.sgml : 20220513 20220513181726 ACCESSION NUMBER: 0001479290-22-000071 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220504 FILED AS OF DATE: 20220513 DATE AS OF CHANGE: 20220513 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Russell Angus C. CENTRAL INDEX KEY: 0001534002 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36297 FILM NUMBER: 22924460 MAIL ADDRESS: STREET 1: C/O INTERMUNE, INC. STREET 2: 3280 BAYSHORE BOULEVARD CITY: BRISBANE STATE: CA ZIP: 94005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Revance Therapeutics, Inc. CENTRAL INDEX KEY: 0001479290 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770551645 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1222 DEMONBREUN STREET STREET 2: SUITE 2000 CITY: NASHVILLE STATE: TN ZIP: 37203 BUSINESS PHONE: 6157247755 MAIL ADDRESS: STREET 1: 1222 DEMONBREUN STREET STREET 2: SUITE 2000 CITY: NASHVILLE STATE: TN ZIP: 37203 4/A 1 wf-form4a_165248019122400.xml FORM 4/A X0306 4/A 2022-05-04 2022-05-06 0 0001479290 Revance Therapeutics, Inc. RVNC 0001534002 Russell Angus C. C/O REVANCE THERAPEUTICS, INC. 1222 DEMONBREUN STREET, SUITE 2000 NASHVILLE TN 37203 1 0 0 0 Stock Option (Right to buy) 18.12 2022-05-04 4 A 0 10756 0 A 2032-05-03 Common Stock 10756.0 10756 D The shares subject to the stock option shall vest on the one year anniversary, May 4, 2023, subject to Mr. Russell's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) through such vesting date. The stock option represents an annual grant pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy. The original Form 4, filed on May 6, 2022, inadvertently listed the incorrect number of options granted to the Reporting Person on May 4, 2022 due to an administrative error. This Form 4/A is being filed to correct the number of shares underlying the stock option originally reported. /s/ Dwight Moxie, Attorney-in-Fact 2022-05-13